ID19063A - Pereaksi peptida untuk deteksi cytomegalovirus (cmv) - Google Patents

Pereaksi peptida untuk deteksi cytomegalovirus (cmv)

Info

Publication number
ID19063A
ID19063A IDP972439A ID972439A ID19063A ID 19063 A ID19063 A ID 19063A ID P972439 A IDP972439 A ID P972439A ID 972439 A ID972439 A ID 972439A ID 19063 A ID19063 A ID 19063A
Authority
ID
Indonesia
Prior art keywords
cmv
detection
antibodies
cytomegalovirus
peptidic
Prior art date
Application number
IDP972439A
Other languages
English (en)
Indonesian (id)
Inventor
Johannes Martinus Ger Crommert
Jaap Michiel Middeldorp
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of ID19063A publication Critical patent/ID19063A/id

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • C07K16/085—Orthoherpesviridae (F), e.g. pseudorabies virus or Epstein-Barr virus
    • C07K16/089—Cytomegalovirus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IDP972439A 1996-07-12 1997-07-14 Pereaksi peptida untuk deteksi cytomegalovirus (cmv) ID19063A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96201972 1996-07-12

Publications (1)

Publication Number Publication Date
ID19063A true ID19063A (id) 1998-06-11

Family

ID=8224180

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP972439A ID19063A (id) 1996-07-12 1997-07-14 Pereaksi peptida untuk deteksi cytomegalovirus (cmv)

Country Status (12)

Country Link
US (1) US6936251B2 (de)
EP (1) EP0960336B1 (de)
JP (1) JP4218985B2 (de)
KR (1) KR100624517B1 (de)
AT (1) ATE225942T1 (de)
AU (1) AU735981B2 (de)
DE (1) DE69716305T2 (de)
DK (1) DK0960336T3 (de)
ES (1) ES2187796T3 (de)
ID (1) ID19063A (de)
WO (1) WO1998002746A1 (de)
ZA (1) ZA976196B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19919121B4 (de) * 1999-04-27 2012-08-02 F. Hoffmann-La Roche Ag Multimeres CMV-Antigen
JP4099058B2 (ja) 2000-10-20 2008-06-11 シティ・オブ・ホープ ヒトサイトメガロウィルスｐｐ１５０の免疫反応性ペプチドｃｔｌエピトープ
AUPR593101A0 (en) * 2001-06-26 2001-07-19 Council Of The Queensland Institute Of Medical Research, The Cytomegalovirus t cell epitopes
ITMI20012160A1 (it) * 2001-10-18 2003-04-18 Edoardo Marchisio Sistema immunoenzimatico per la caratterizzazione antigenica dell'infezione attiva da cytomegalovirus e cmv confirmation test
US7947274B2 (en) 2007-01-04 2011-05-24 Humabs, LLC. Human cytomegalovirus neutralising antibodies and use thereof
GB0700133D0 (en) 2007-01-04 2007-02-14 Humabs Llc Human cytomegalovirus neutralising antibodies and use thereof
CN101605808A (zh) * 2007-02-07 2009-12-16 希格马托制药工业公司 人巨细胞病毒(hcmv)的重组抗原
PT3009449T (pt) 2008-07-16 2018-09-28 Inst Res Biomedicine Anticorpos neutralizantes de citomegalovírus humano e utilização destes
WO2010148541A1 (zh) * 2009-06-26 2010-12-29 鑫品生医科技股份有限公司 含衍生自细胞巨大病毒的胜肽的免疫原组成物及使用方法
JP5712513B2 (ja) * 2010-07-07 2015-05-07 富士レビオ株式会社 ヒトサイトメガロウイルス感染の検出方法
NZ591514A (en) * 2011-03-03 2013-11-29 Kode Biotech Ltd Assay method
US10611800B2 (en) 2016-03-11 2020-04-07 Pfizer Inc. Human cytomegalovirus gB polypeptide
US11629172B2 (en) 2018-12-21 2023-04-18 Pfizer Inc. Human cytomegalovirus gB polypeptide
US11857622B2 (en) 2020-06-21 2024-01-02 Pfizer Inc. Human cytomegalovirus GB polypeptide
CN116298269A (zh) * 2022-08-17 2023-06-23 浙江大学医学院附属第一医院 人类巨细胞病毒重组抗原特异性IgG抗体的酶联免疫检测试剂盒

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987003602A1 (fr) * 1985-12-06 1987-06-18 Teijin Limited Anticorps monoclonal humain contre le virus megalocytique et procede de preparation dudit anticorps
CA1335429C (en) * 1986-03-07 1995-05-02 Geoffrey L. Smith Processes for the production of hcmv glycoproteins, antibodies thereto and hcmv vaccines, and recombinant vectors therefor
DE3619902A1 (de) * 1986-06-13 1988-03-03 Biotechnolog Forschung Gmbh Cmv-dna-strukturen, expressionsvektor dafuer, cmv-proteinstrukturen und deren verwendung
ATE132533T1 (de) * 1988-02-24 1996-01-15 Behringwerke Ag Strukturelles phosphoprotein (pp28) des menschlichen cytomegalovirus (hcmv), seine herstellung und verwendung
GB9014652D0 (en) * 1990-07-02 1990-08-22 Wellcome Found Antigen
DE4128684A1 (de) 1991-08-29 1993-03-04 Behringwerke Ag Hcmv-spezifische peptide, mittel dazu und ihre verwendung
US5744298A (en) 1991-08-29 1998-04-28 Behringwerke Aktiengesellschaft DNA sequences which encode immunoreactive HCMV-specific peptides
IT1266740B1 (it) * 1994-07-01 1997-01-14 Maria Paola Landini Materiale proteico ricombinante legante anticorpi contro il citomegalovirus umano, reagenti diagnostici derivati da tale
EP0702083A3 (de) 1994-07-26 1997-01-15 Biotest Ag Polypeptide und Fusionsproteine bestehend aus dem UL 57 Leserahmen bzw. dem C-terminalen Bereich des Tegumentproteins pp150 aus HCMV, entsprechende Oligonucleotide und Nachweis reagentien
DE4426453C1 (de) * 1994-07-26 1995-11-02 Biotest Ag Rekombinant hergestellte Fusionsproteine des Cytomegalievirus und diese enthaltende diagnostische Testkits

Also Published As

Publication number Publication date
US20030119039A1 (en) 2003-06-26
JP2000514300A (ja) 2000-10-31
EP0960336A1 (de) 1999-12-01
ZA976196B (en) 1998-09-01
DK0960336T3 (da) 2003-02-10
AU735981B2 (en) 2001-07-19
AU3623197A (en) 1998-02-09
KR100624517B1 (ko) 2006-09-18
ATE225942T1 (de) 2002-10-15
DE69716305D1 (de) 2002-11-14
DE69716305T2 (de) 2003-06-26
JP4218985B2 (ja) 2009-02-04
WO1998002746A1 (en) 1998-01-22
ES2187796T3 (es) 2003-06-16
KR20000023701A (ko) 2000-04-25
US6936251B2 (en) 2005-08-30
EP0960336B1 (de) 2002-10-09

Similar Documents

Publication Publication Date Title
DE69716305D1 (de) Peptidereagenz zum nachweis von humanem cytomegalovirus (cmv)
BR9809443A (pt) Polipeptìdeo compreendendo uma porção antigênica de um antìgeno de m. tuberculosis, molécula de dna, vetor recombinante de expressão, célula hospedeira, processo para detecção de infecção de m. tuberculosis em uma amostra biológica, kit de diganóstico, anticorpo monoclonal, anticorpo policlonal, e, proteìna de fusão.
DK104093D0 (da) Fremgangsmaade til bestemmelse af collagen-fragmenter i legemsvaesker, test-kit og midler til udoevelse af fremgangsmaaden og anvendelse af fremgangsmaaden til diagnosticering af lidelser associeret til collagen-metabolismen
ATE437364T1 (de) Detektion von peptiden
SE9500023D0 (sv) Method of detecting cancer
BR9712298A (pt) Polipeptìdeo, molécula de dna, vetor de expressão recombinante, célula hospedeira, processo para detectar infecção por m. tuberculosis em uma amostra biológica, kit diagnóstico, anticorpos monoclonal, e, policlonal, e, proteìna de fusão
EP2048505A3 (de) Verfahren zur Früherkennung der Serokonversion eines gegen Hepatitis C-Virus gerichteten Antikörpers
ATE258310T1 (de) Testverfahren für collagenpeptid
DK0747481T3 (da) Epstein-Barr-viruspeptider og antistoffer mod disse peptider
GR3018371T3 (en) Method for identifying or determining proteins and applications therefor.
ATE366420T1 (de) Kit und verfahren zur bestimmung von protein esm- 1
DE69638024D1 (de) Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren
ATE306666T1 (de) Verfahren zur eiweissanalyse
DK0607425T3 (da) Epstein-Barr-viruspeptider og antistoffer mod disse peptider
WO1992007939A3 (en) Polypeptide with 46kd hmfg differentiation antigen binding specificity
ATE297470T1 (de) Expression kassette eines proteines p30 aus toxoplasma gondii
CA2259967A1 (en) Peptide reagent for the detection of human cytomegalovirus (cmv)
NO983984L (no) Disintegrin-metalloprotease samt anvendelse derav
ATE228249T1 (de) Immuntest zum nachweis von menschlichen cytomegalovirus spezifischen igm
WO2001015655A3 (en) Peptides and substances, methods and devices using same for diagnosing and treating neurodegenerative disorders
ATE271067T1 (de) An menschliches wachstumshormon (hgh) bindende monoklonale antikörper
FI20002225A7 (fi) Diagnostinen menetelmä
HUP9902836A2 (hu) Eljárások az S-100 jelű agyi fehérje meghatározására
AR013326A1 (es) POLIPEPTIDO AISLADO, MOLECULA DE ADN, VECTOR DE EXPRESION RECOMBINANTE, CELULA HUESPED, METODO PARa DETECTAR LA INFECCION DE M.TUBERCULOSIS EN UNAMUESTRA BIOLOGICA, EQUIPO PARA DIAGNOSTICO, ANTICUERPO MONOCLONAL, Y ANTICUERPO POLICLONAL, PROTEINAS DE FUSION